Pragnesh Donga

Decoding FDA Complete Response Letters: Regulatory Challenges and Strategies for Successful Drug Approval

It is highlighted that major deficiencies in USFDA drug approval submissions, particularly in CMC and clinical areas, are commonly associated with poor data quality, inadequate validation, incomplete documentation, and insufficient safety and efficacy evidence.